{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:22:53Z","timestamp":1794846173728,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82127807"],"award-info":[{"award-number":["82127807"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2023,1,3]]},"DOI":"10.1038\/s41388-022-02528-y","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T04:32:47Z","timestamp":1668054767000},"page":"35-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["TNF\u03b1-induced IDH1 hyperacetylation reprograms redox homeostasis and promotes the chemotherapeutic sensitivity"],"prefix":"10.1038","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3781-7271","authenticated-orcid":false,"given":"Hao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunchi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8131-8886","authenticated-orcid":false,"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8983-4137","authenticated-orcid":false,"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5786-7110","authenticated-orcid":false,"given":"Gang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"2528_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41575-019-0230-y","volume":"17","author":"G Jung","year":"2020","unstructured":"Jung G, Hern\u00e1ndez-Ill\u00e1n E, Moreira L, Balaguer F, Goel A. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol. 2020;17:111\u201330.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2528_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"2528_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","volume":"5","author":"YH Xie","year":"2020","unstructured":"Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther. 2020;5:22.","journal-title":"Signal Transduct Target Ther"},{"key":"2528_CR4","doi-asserted-by":"publisher","first-page":"107447","DOI":"10.1016\/j.pharmthera.2019.107447","volume":"206","author":"S Vodenkova","year":"2020","unstructured":"Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharm Ther. 2020;206:107447.","journal-title":"Pharm Ther"},{"key":"2528_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.bbcan.2019.01.002","volume":"1871","author":"K Kryeziu","year":"2019","unstructured":"Kryeziu K, Bruun J, Guren TK, Sveen A, Lothe RA. Combination therapies with HSP90 inhibitors against colorectal cancer. Biochim Biophys Acta Rev Cancer. 2019;1871:240\u20137.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2528_CR6","doi-asserted-by":"publisher","first-page":"188447","DOI":"10.1016\/j.bbcan.2020.188447","volume":"1874","author":"DY Lizardo","year":"2020","unstructured":"Lizardo DY, Kuang C, Hao S, Yu J, Huang Y, Zhang L. Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: from bench to bedside. Biochim Biophys Acta Rev Cancer. 2020;1874:188447.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2528_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-019-00489-1","volume":"43","author":"D Cruceriu","year":"2020","unstructured":"Cruceriu D, Baldasici O, Balacescu O, Berindan-Neagoe I. The dual role of tumor necrosis factor-alpha (TNF-\u03b1) in breast cancer: molecular insights and therapeutic approaches. Cell Oncol (Dordr). 2020;43:1\u201318.","journal-title":"Cell Oncol (Dordr)"},{"key":"2528_CR8","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1038\/onc.2014.286","volume":"34","author":"V De Simone","year":"2015","unstructured":"De Simone V, Franz\u00e8 E, Ronchetti G, Colantoni A, Fantini MC, Di Fusco D, et al. Th17-type cytokines, IL-6 and TNF-\u03b1 synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene. 2015;34:3493\u2013503.","journal-title":"Oncogene"},{"key":"2528_CR9","doi-asserted-by":"publisher","first-page":"e12441","DOI":"10.1111\/cpr.12441","volume":"51","author":"J Shen","year":"2018","unstructured":"Shen J, Xiao Z, Zhao Q, Li M, Wu X, Zhang L, et al. Anti-cancer therapy with TNF\u03b1 and IFN\u03b3: a comprehensive review. Cell Prolif. 2018;51:e12441.","journal-title":"Cell Prolif"},{"key":"2528_CR10","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.1158\/1078-0432.CCR-11-1026","volume":"17","author":"JH Lee","year":"2011","unstructured":"Lee JH, Kang MJ, Han HY, Lee MG, Jeong SI, Ryu BK, et al. Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNF\u03b1-induced apoptosis. Clin Cancer Res. 2011;17:7551\u201362.","journal-title":"Clin Cancer Res"},{"key":"2528_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jconrel.2015.05.282","volume":"210","author":"L Lu","year":"2015","unstructured":"Lu L, Li ZJ, Li LF, Wu WK, Shen J, Zhang L, et al. Vascular-targeted TNF\u03b1 improves tumor blood vessel function and enhances antitumor immunity and chemotherapy in colorectal cancer. J Control Release. 2015;210:134\u201346.","journal-title":"J Control Release"},{"key":"2528_CR12","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1038\/onc.2015.523","volume":"35","author":"A Fluckiger","year":"2016","unstructured":"Fluckiger A, Dumont A, Derang\u00e8re V, R\u00e9b\u00e9 C, de Rosny C, Causse S, et al. Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNF\u03b1. Oncogene. 2016;35:4611\u201322.","journal-title":"Oncogene"},{"key":"2528_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri3834","volume":"15","author":"D Brenner","year":"2015","unstructured":"Brenner D, Blaser H, Mak TW. Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol. 2015;15:362\u201374.","journal-title":"Nat Rev Immunol"},{"key":"2528_CR14","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.3892\/ijo.2015.3189","volume":"47","author":"W Walther","year":"2015","unstructured":"Walther W, Kobelt D, Bauer L, Aumann J, Stein U. Chemosensitization by diverging modulation by short-term and long-term TNF-\u03b1 action on ABCB1 expression and NF-\u03baB signaling in colon cancer. Int J Oncol. 2015;47:2276\u201385.","journal-title":"Int J Oncol"},{"key":"2528_CR15","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.celrep.2017.05.014","volume":"19","author":"AE Calvert","year":"2017","unstructured":"Calvert AE, Chalastanis A, Wu Y, Hurley LA, Kouri FM, Bi Y, et al. Cancer-associated IDH1 promotes growth and resistance to targeted therapies in the absence of mutation. Cell Rep. 2017;19:1858\u201373.","journal-title":"Cell Rep"},{"key":"2528_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature17393","volume":"532","author":"L Jiang","year":"2016","unstructured":"Jiang L, Shestov AA, Swain P, Yang C, Parker SJ, Wang QA, et al. Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature 2016;532:255\u20138.","journal-title":"Nature"},{"key":"2528_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s42255-019-0043-x","volume":"1","author":"L Chen","year":"2019","unstructured":"Chen L, Zhang Z, Hoshino A, Zheng HD, Morley M, Arany Z, et al. NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism. Nat Metab. 2019;1:404\u201315.","journal-title":"Nat Metab"},{"key":"2528_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0537-6","volume":"9","author":"MJ Kong","year":"2018","unstructured":"Kong MJ, Han SJ, Kim JI, Park JW, Park KM. Mitochondrial NADP(+)-dependent isocitrate dehydrogenase deficiency increases cisplatin-induced oxidative damage in the kidney tubule cells. Cell Death Dis. 2018;9:488.","journal-title":"Cell Death Dis"},{"key":"2528_CR19","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.7150\/jca.58846","volume":"12","author":"H Yang","year":"2021","unstructured":"Yang H, Xie S, Liang B, Tang Q, Liu H, Wang D, et al. Exosomal IDH1 increases the resistance of colorectal cancer cells to 5-Fluorouracil. J Cancer. 2021;12:4862\u201372.","journal-title":"J Cancer"},{"key":"2528_CR20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3390\/biom11050740","volume":"11","author":"J Weeks","year":"2021","unstructured":"Weeks J, Strom AI, Widjaja V, Alexander S, Pucher DK, Sohl CD. Evaluating mechanisms of IDH1 regulation through site-specific acetylation mimics. Biomolecules. 2021;11:740.","journal-title":"Biomolecules"},{"key":"2528_CR21","doi-asserted-by":"publisher","first-page":"e48183","DOI":"10.15252\/embr.201948183","volume":"21","author":"B Wang","year":"2020","unstructured":"Wang B, Ye Y, Yang X, Liu B, Wang Z, Chen S, et al. SIRT2-dependent IDH1 deacetylation inhibits colorectal cancer and liver metastases. EMBO Rep. 2020;21:e48183.","journal-title":"EMBO Rep"},{"key":"2528_CR22","doi-asserted-by":"publisher","first-page":"14078","DOI":"10.1074\/jbc.M112.355206","volume":"287","author":"W Yu","year":"2012","unstructured":"Yu W, Dittenhafer-Reed KE, Denu JM. SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. J Biol Chem. 2012;287:14078\u201386.","journal-title":"J Biol Chem"},{"key":"2528_CR23","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1073\/pnas.1302961110","volume":"110","author":"MJ Rardin","year":"2013","unstructured":"Rardin MJ, Newman JC, Held JM, Cusack MP, Sorensen DJ, Li B, et al. Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways. Proc Natl Acad Sci USA. 2013;110:6601\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2528_CR24","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1158\/1078-0432.CCR-17-3081","volume":"24","author":"V Carafa","year":"2018","unstructured":"Carafa V, Nebbioso A, Cuomo F, Rotili D, Cobellis G, Bontempo P, et al. RIP1\u2013HAT1\u2013SIRT complex identification and targeting in treatment and prevention of cancer. Clin Cancer Res. 2018;24:2886\u2013900.","journal-title":"Clin Cancer Res"},{"key":"2528_CR25","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1038\/s41388-018-0221-4","volume":"37","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Lin G, Yan Y, Li X, Hu Y, Wang J, et al. Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells. Oncogene. 2018;37:3456\u201370.","journal-title":"Oncogene"},{"key":"2528_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","volume":"150","author":"S Acharyya","year":"2012","unstructured":"Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell. 2012;150:165\u201378.","journal-title":"Cell"},{"key":"2528_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/ni.3384","volume":"17","author":"A Lasry","year":"2016","unstructured":"Lasry A, Zinger A, Ben-Neriah Y. Inflammatory networks underlying colorectal cancer. Nat Immunol. 2016;17:230\u201340.","journal-title":"Nat Immunol"},{"key":"2528_CR28","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1038\/onc.2015.398","volume":"35","author":"M Oliver Metzig","year":"2016","unstructured":"Oliver Metzig M, Fuchs D, Tagscherer KE, Gr\u00f6ne HJ, Schirmacher P, Roth W. Inhibition of caspases primes colon cancer cells for 5-fluorouracil-induced TNF-\u03b1-dependent necroptosis driven by RIP1 kinase and NF-\u03baB. Oncogene. 2016;35:3399\u2013409.","journal-title":"Oncogene"},{"key":"2528_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9:361\u201371.","journal-title":"Nat Rev Cancer"},{"key":"2528_CR30","doi-asserted-by":"publisher","first-page":"100663","DOI":"10.1016\/j.drup.2019.100663","volume":"48","author":"S Narayanan","year":"2020","unstructured":"Narayanan S, Cai CY, Assaraf YG, Guo HQ, Cui Q, Wei L, et al. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance. Drug Resist Updat. 2020;48:100663.","journal-title":"Drug Resist Updat"},{"key":"2528_CR31","doi-asserted-by":"publisher","first-page":"e132306","DOI":"10.1172\/jci.insight.132306","volume":"5","author":"AD denDekker","year":"2020","unstructured":"denDekker AD, Davis FM, Joshi AD, Wolf SJ, Allen R, Lipinski J, et al. TNF-\u03b1 regulates diabetic macrophage function through the histone acetyltransferase MOF. JCI Insight. 2020;5:e132306.","journal-title":"JCI Insight"},{"key":"2528_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.canlet.2008.09.013","volume":"274","author":"DO Moon","year":"2009","unstructured":"Moon DO, Kim MO, Kang SH, Choi YH, Kim GY. Sulforaphane suppresses TNF-alpha-mediated activation of NF-kappaB and induces apoptosis through activation of reactive oxygen species-dependent caspase-3. Cancer Lett. 2009;274:132\u201342.","journal-title":"Cancer Lett"},{"key":"2528_CR33","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1007\/s00262-021-02862-2","volume":"70","author":"F Meng","year":"2021","unstructured":"Meng F, Yang M, Chen Y, Chen W, Wang W. miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1\/NF-\u03baB\/B7-H3\/TNF-\u03b1 axis. Cancer Immunol Immunother. 2021;70:2247\u201359.","journal-title":"Cancer Immunol Immunother"},{"key":"2528_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2016.02.015","volume":"376","author":"J Hou","year":"2016","unstructured":"Hou J, Wang T, Xie Q, Deng W, Yang JY, Zhang SQ, et al. N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-\u03baB\/p65. Cancer Lett. 2016;376:22\u201333.","journal-title":"Cancer Lett"},{"key":"2528_CR35","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/onc.2013.179","volume":"33","author":"Z Zou","year":"2014","unstructured":"Zou Z, Huang B, Wu X, Zhang H, Qi J, Bradner J, et al. Brd4 maintains constitutively active NF-\u03baB in cancer cells by binding to acetylated RelA. Oncogene. 2014;33:2395\u2013404.","journal-title":"Oncogene"},{"key":"2528_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jhep.2018.08.026","volume":"70","author":"T Zhang","year":"2019","unstructured":"Zhang T, Hu J, Wang X, Zhao X, Li Z, Niu J, et al. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-\u03baB-TNF\u03b1 pathway. J Hepatol. 2019;70:87\u201396.","journal-title":"J Hepatol"},{"key":"2528_CR37","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ejmech.2015.08.024","volume":"102","author":"G Sociali","year":"2015","unstructured":"Sociali G, Galeno L, Parenti MD, Grozio A, Bauer I, Passalacqua M, et al. Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics. Eur J Med Chem. 2015;102:530\u20139.","journal-title":"Eur J Med Chem"},{"key":"2528_CR38","first-page":"1987","volume":"18","author":"B Liu","year":"2018","unstructured":"Liu B, Xu L, Yu X, Li W, Sun X, Xiao S, et al. Protective effect of KLF15 on vascular endothelial dysfunction induced by TNF\u2011\u03b1. Mol Med Rep. 2018;18:1987\u201394.","journal-title":"Mol Med Rep"},{"key":"2528_CR39","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3389\/fimmu.2020.00980","volume":"11","author":"D Kobelt","year":"2020","unstructured":"Kobelt D, Zhang C, Clayton-Lucey IA, Glauben R, Voss C, Siegmund B, et al. Pro-inflammatory TNF-\u03b1 and IFN-\u03b3 promote tumor growth and metastasis via induction of MACC1. Front Immunol. 2020;11:980.","journal-title":"Front Immunol"},{"key":"2528_CR40","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1158\/1078-0432.CCR-15-0375","volume":"21","author":"V De Rosa","year":"2015","unstructured":"De Rosa V, Iommelli F, Monti M, Fonti R, Votta G, Stoppelli MP, et al. Reversal of Warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non-small cell lung cancer. Clin Cancer Res. 2015;21:5110\u201320.","journal-title":"Clin Cancer Res"},{"key":"2528_CR41","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/s41401-020-00546-8","volume":"42","author":"M Tian","year":"2021","unstructured":"Tian M, Chen XS, Li LY, Wu HZ, Zeng D, Wang XL, et al. Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis. Acta Pharm Sin. 2021;42:1180\u20139.","journal-title":"Acta Pharm Sin"},{"key":"2528_CR42","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41422-018-0086-7","volume":"28","author":"ST Sizemore","year":"2018","unstructured":"Sizemore ST, Zhang M, Cho JH, Sizemore GM, Hurwitz B, Kaur B, et al. Pyruvate kinase M2 regulates homologous recombination-mediated DNA double-strand break repair. Cell Res. 2018;28:1090\u2013102.","journal-title":"Cell Res"},{"key":"2528_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01106-1","volume":"8","author":"K Shanmugasundaram","year":"2017","unstructured":"Shanmugasundaram K, Nayak BK, Friedrichs WE, Kaushik D, Rodriguez R, Block K. NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance. Nat Commun. 2017;8:997.","journal-title":"Nat Commun"},{"key":"2528_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13601-8","volume":"11","author":"H Nie","year":"2020","unstructured":"Nie H, Ju H, Fan J, Shi X, Cheng Y, Cang X, et al. O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth. Nat Commun. 2020;11:36.","journal-title":"Nat Commun"},{"key":"2528_CR45","doi-asserted-by":"publisher","first-page":"e1002243","DOI":"10.1371\/journal.pbio.1002243","volume":"13","author":"S Wang","year":"2015","unstructured":"Wang S, Jiang B, Zhang T, Liu L, Wang Y, Wang Y, et al. Insulin and mTOR pathway regulate HDAC3-mediated deacetylation and activation of PGK1. PLoS Biol. 2015;13:e1002243.","journal-title":"PLoS Biol"},{"key":"2528_CR46","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/hep.28887","volume":"65","author":"H Hu","year":"2017","unstructured":"Hu H, Zhu W, Qin J, Chen M, Gong L, Li L, et al. Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis. Hepatology. 2017;65:515\u201328.","journal-title":"Hepatology"},{"key":"2528_CR47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molcel.2018.06.023","volume":"71","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Yu G, Chu H, Wang X, Xiong L, Cai G, et al. Macrophage-associated PGK1 phosphorylation promotes aerobic glycolysis and tumorigenesis. Mol Cell. 2018;71:201.e207.","journal-title":"Mol Cell"},{"key":"2528_CR48","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1038\/s41388-017-0077-z","volume":"37","author":"RJ Molenaar","year":"2018","unstructured":"Molenaar RJ, Maciejewski JP, Wilmink JW, van Noorden CJF. Wild-type and mutated IDH1\/2 enzymes and therapy responses. Oncogene. 2018;37:1949\u201360.","journal-title":"Oncogene"},{"key":"2528_CR49","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/neuonc\/noaa180","volume":"23","author":"JJ Miller","year":"2021","unstructured":"Miller JJ, Fink A, Banagis JA, Nagashima H, Subramanian M, Lee CK, et al. Sirtuin activation targets IDH-mutant tumors. Neuro Oncol. 2021;23:53\u201362.","journal-title":"Neuro Oncol"},{"key":"2528_CR50","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.3390\/cancers11122028","volume":"11","author":"J Biedermann","year":"2019","unstructured":"Biedermann J, Preussler M, Conde M, Peitzsch M, Richter S, Wiedemuth R, et al. Mutant IDH1 differently affects redox state and metabolism in glial cells of normal and tumor origin. Cancers (Basel). 2019;11:2028.","journal-title":"Cancers (Basel)"},{"key":"2528_CR51","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1111\/cas.15116","volume":"112","author":"F Xu","year":"2021","unstructured":"Xu F, Hua Q, Zhang A, Di Z, Wang Y, Zhao L, et al. LncRNA AC020978 facilitates non-small cell lung cancer progression by interacting with malate dehydrogenase 2 and activating the AKT pathway. Cancer Sci. 2021;112:4501\u201314.","journal-title":"Cancer Sci"},{"key":"2528_CR52","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3390\/biom10030358","volume":"10","author":"AA Pramono","year":"2020","unstructured":"Pramono AA, Rather GM, Herman H, Lestari K, Bertino JR. NAD- and NADPH-contributing enzymes as therapeutic targets in cancer: an overview. Biomolecules. 2020;10:358.","journal-title":"Biomolecules"},{"key":"2528_CR53","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/ajcp\/aqab023","volume":"156","author":"J Huang","year":"2021","unstructured":"Huang J, Tseng LH, Parini V, Lokhandwala PM, Pallavajjala A, Rodriguez E, et al. IDH1 and IDH2 mutations in colorectal cancers. Am J Clin Pathol. 2021;156:777\u201386.","journal-title":"Am J Clin Pathol"},{"key":"2528_CR54","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ccell.2017.12.004","volume":"33","author":"R Yaeger","year":"2018","unstructured":"Yaeger R, Chatila WK, Lipsyc MD, Hechtman JF, Cercek A, Sanchez-Vega F, et al. Clinical sequencing defines the genomic landscape of metastatic colorectal cancer. Cancer Cell. 2018;33:125.e123.","journal-title":"Cancer Cell"},{"key":"2528_CR55","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/s41401-019-0225-9","volume":"40","author":"CJ Han","year":"2019","unstructured":"Han CJ, Zheng JY, Sun L, Yang HC, Cao ZQ, Zhang XH, et al. The oncometabolite 2-hydroxyglutarate inhibits microglial activation via the AMPK\/mTOR\/NF-\u03baB pathway. Acta Pharm Sin. 2019;40:1292\u2013302.","journal-title":"Acta Pharm Sin"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02528-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T16:03:48Z","timestamp":1672761828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02528-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,3]]}},"alternative-id":["2528"],"URL":"https:\/\/doi.org\/10.1038\/s41388-022-02528-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"assertion":[{"value":"8 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}